Ziegelstein R C
Department of Medicine, Division of Cardiology, Johns Hopkins Bayview Medical Center, 4940 Eastern Ave, Baltimore, MD 21224-2780, USA.
JAMA. 2001 Oct 3;286(13):1621-7. doi: 10.1001/jama.286.13.1621.
Depression is common among patients recovering from a myocardial infarction (MI). Approximately 1 in 6 patients with MI experience major depression and at least twice as many as that have significant symptoms of depression soon after the event. Post-MI depression is an independent risk factor for increased mortality. Although the mechanism responsible for this association has not yet been defined, depression is clearly associated with poor compliance with risk-reducing recommendations, with abnormalities in autonomic tone that may make patients more susceptible to ventricular arrhythmias, and with increased platelet activation. Coronary revascularization procedures also appear to be used less often in those with post-MI depression than in comparable patients without mood disorder. Ongoing research will address whether treating depression improves prognosis. Until this question is answered, efforts should focus on enhancing adherence to treatment regimens in this group of patients, who are clearly at risk for noncompliance. Cardiac rehabilitation programs and increasing levels of social support may help improve symptoms and should be recommended to all patients. Treatment of depression itself should be individualized until safety and efficacy are determined for antidepressant therapy in patients who recently have had an MI.
抑郁症在心肌梗死(MI)康复患者中很常见。约六分之一的心肌梗死患者患有重度抑郁症,且至少有两倍于此数量的患者在发病后不久出现明显的抑郁症状。心肌梗死后抑郁症是死亡率增加的独立危险因素。尽管这种关联的机制尚未明确,但抑郁症显然与降低风险建议的依从性差、自主神经张力异常(这可能使患者更容易发生室性心律失常)以及血小板活化增加有关。与没有情绪障碍的可比患者相比,心肌梗死后抑郁症患者接受冠状动脉血运重建手术的频率似乎也较低。正在进行的研究将探讨治疗抑郁症是否能改善预后。在这个问题得到解答之前,应将努力重点放在提高这类明显存在不依从风险的患者对治疗方案的依从性上。心脏康复计划和增加社会支持水平可能有助于改善症状,应推荐给所有患者。在确定近期发生心肌梗死的患者使用抗抑郁药治疗的安全性和有效性之前,抑郁症本身的治疗应个体化。